drugset / Trial / NCT00003223

SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth

NCT00003223

NaSingle-groupOpen-labelPrevention

Summary

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of fenretinide may be an effective way to prevent the development of cancer in patients with neoplasia of the mouth. PURPOSE: Phase II trial to study the effectiveness of fenretinide in preventing cancer in patients who have neoplasia of the mouth.

Timeline

Start
1997-12
Primary completion
2000-03
Completion
2000-03

Drugs

EvaluationDrugModalityDoseRoute
Subject fenretinide Small molecule 200 mg Oral

Indications